Automated description from the Alliance of Genome Resources (Release 7.4.0)
Enables cyclin-dependent protein serine/threonine kinase inhibitor activity and protein kinase binding activity. Acts upstream of or within negative regulation of cyclin-dependent protein serine/threonine kinase activity and negative regulation of stem cell proliferation. Predicted to be located in cytoplasm and nucleus. Is expressed in several structures, including alimentary system; genitourinary system; integumental system; nervous system; and respiratory system. Used to study breast cancer. Orthologous to human CDKN2C (cyclin dependent kinase inhibitor 2C).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.